JPS5673047A - Decaprenylamine derivative - Google Patents

Decaprenylamine derivative

Info

Publication number
JPS5673047A
JPS5673047A JP14882179A JP14882179A JPS5673047A JP S5673047 A JPS5673047 A JP S5673047A JP 14882179 A JP14882179 A JP 14882179A JP 14882179 A JP14882179 A JP 14882179A JP S5673047 A JPS5673047 A JP S5673047A
Authority
JP
Japan
Prior art keywords
formula
decaprenylamine
derivative
amino compound
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14882179A
Other languages
English (en)
Other versions
JPS6252739B2 (ja
Inventor
Yoshiyuki Tawara
Hiroyasu Koyama
Yasuhiro Komatsu
Reiko Kubota
Toshihiro Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Seifun Group Inc
Original Assignee
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Seifun Group Inc filed Critical Nisshin Seifun Group Inc
Priority to JP14882179A priority Critical patent/JPS5673047A/ja
Priority to DE19803043446 priority patent/DE3043446A1/de
Priority to FR8024595A priority patent/FR2470111B1/fr
Priority to GB8037115A priority patent/GB2065110B/en
Publication of JPS5673047A publication Critical patent/JPS5673047A/ja
Priority to US06/362,674 priority patent/US4431811A/en
Publication of JPS6252739B2 publication Critical patent/JPS6252739B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP14882179A 1979-11-19 1979-11-19 Decaprenylamine derivative Granted JPS5673047A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP14882179A JPS5673047A (en) 1979-11-19 1979-11-19 Decaprenylamine derivative
DE19803043446 DE3043446A1 (de) 1979-11-19 1980-11-18 Decaprenylaminderivate
FR8024595A FR2470111B1 (fr) 1979-11-19 1980-11-19 Derives de la decaprenylamine, leurs sels acides d'addition et composition pharmaceutique utilisant ces produits
GB8037115A GB2065110B (en) 1979-11-19 1980-11-19 Decaprenylamine derivatives
US06/362,674 US4431811A (en) 1979-11-19 1982-03-29 Decaprenylamine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14882179A JPS5673047A (en) 1979-11-19 1979-11-19 Decaprenylamine derivative

Publications (2)

Publication Number Publication Date
JPS5673047A true JPS5673047A (en) 1981-06-17
JPS6252739B2 JPS6252739B2 (ja) 1987-11-06

Family

ID=15461466

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14882179A Granted JPS5673047A (en) 1979-11-19 1979-11-19 Decaprenylamine derivative

Country Status (4)

Country Link
JP (1) JPS5673047A (ja)
DE (1) DE3043446A1 (ja)
FR (1) FR2470111B1 (ja)
GB (1) GB2065110B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57192339A (en) * 1981-05-18 1982-11-26 Nisshin Flour Milling Co Ltd Isoprenylamine derivative
JPS57192342A (en) * 1981-05-18 1982-11-26 Nisshin Flour Milling Co Ltd Isoprenylamine derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3444202A (en) * 1966-05-12 1969-05-13 Shell Oil Co Production of n-(2,7,11(15)-alkapolyenyl)amines
US4139560A (en) * 1974-02-22 1979-02-13 Ciba Geigy Corporation Nonylamines

Also Published As

Publication number Publication date
FR2470111A1 (fr) 1981-05-29
DE3043446C2 (ja) 1989-01-05
DE3043446A1 (de) 1981-08-27
GB2065110B (en) 1983-09-28
FR2470111B1 (fr) 1985-07-19
JPS6252739B2 (ja) 1987-11-06
GB2065110A (en) 1981-06-24

Similar Documents

Publication Publication Date Title
IL85988A (en) 1-phenyl-3-naphthalenyloxy-propanamines,process for their preparation and pharmaceutical compositions containing them
EP0353955A3 (en) Novel compounds
JPS56115784A (en) Novel pyridinecarboxamide derivative and its preparation
ES8306142A1 (es) "procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil)-bencimidazolonas sustituidas".
PT82368A (en) Substituted n-<(4-piperidinyl)alkyl> bicyclic condensed oxazol- and thiazolamines
DE2964903D1 (en) 2-lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds, processes for their preparation and pharmaceutical compositions containing them
EP0353821A3 (en) Antipsychotic 3-piperazinyl-benzazole derivatives
EP0288962A3 (en) Aryl-aralkyl ethers, processes for their preparation and pharmaceutical composition comprising them
IL85919A (en) Pharmaceutical compositions for improving sleep comprising n-aryl- piperazinealkanamide derivatives, certain such novel compounds and their preparation
SE7906011L (sv) Nya imidazokinoxaliner och salter derav, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar
DE3164314D1 (en) Azolylalkyl derivatives, process for their preparation and their use as fungicides
JPS5673047A (en) Decaprenylamine derivative
JPS56150002A (en) Nonaprenylamine derivative
JPS5673046A (en) Decaprenylamine derivative
EP0205299A3 (en) Isatin derivatives, compositions containing the same, and the use thereof for ulcer diseases
JPS56150047A (en) Nonaprenylamine derivative
JPS5764639A (en) Novel stilbene derivative, its preparation, and medical composition containing the same as active ingredent
ES8201575A1 (es) Procedimiento de obtencion de nuevos 2-aminoetanoles
ES487971A1 (es) Procedimiento para la preparacion de nuevos derivados de p-cloroacetofenona oxima con actividad analgesica
JPS6463520A (en) Prolactin secretion inhibitor
JPS5592360A (en) M-sulfonamido-benzamides
JPS5673072A (en) Decaprenylamine derivative
EP0035270A3 (en) Heterocyclic compounds, compositions thereof, their preparation and use
JPS57139083A (en) Cephalosporin derivative
JPS57181048A (en) Chloroalkenoic acid amide derivative, its preparation, and herbicide containing the same